AIU hands Kasait 10 month ban for using hormone therapy drug

AIU hands Kasait 10 month ban for using hormone therapy drug

Kasait’s ban took effect in April this year after she returned a positive test for the banned substance, Letrozole in an out of competition test on 20 January 2022.

Kasait Rengeruk (right) finished 12th in the women's 5000m final at the Tokyo Olympics last year

Reigning African 5000m champion and 2017 World Cross Country bronze medalist Lilian Kasait has been slapped with a 10 month ban by the World Athletics Athlete Integrity Unit (AIU) for doping violations.

Kasait also took part at the 2020 Olympics, finishing 12th in the women’s 5000m final.

Kasait’s ban took effect in April this year after she returned a positive test for the banned substance, Letrozole in an out of competition test on 20 January 2022.

Letrozole is in a class of medications called nonsteroidal aromatase inhibitors. It works by decreasing the amount of estrogen produced by the body.

The former All-African Games and national champion's suspension will run from April 2022 to February 2023 because she admitted her guilt.

"Taking into consideration how promptly the athlete admitted the anti-doping rule violations upon notification, the parties agree that the period of ineligibility shall be backdated," the AIU said in a statement.

Kasait is the eighth Kenyan to be banned for a positive doping test since the beginning of July.

Read more on : Athletics

Recommended to you